Pilosanol A



Compound IDCDAMM01651
Common namePilosanol A
IUPAC name1-[3-[[2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-3,4-dihydro-2H-chromen-8-yl]methyl]-2,4-dihydroxy-6-methoxy-5-methylphenyl]-2-methylbutan-1-one
Molecular formulaC29H32O10

Experimental data

Retention time0.36
Adduct[M+K]+
Actual mz579.16
Theoretical mz579.163
Error5.45
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score7.2749

Identifiers and class information

Inchi keyAXODAJZSINDBPB-QJFKVZSGNA-N
SmilesO=C(C=1C(O)=C(C(O)=C(C1OC)C)CC2=C(O)C=C(O)C3=C2OC(C4=CC=C(O)C(O)=C4)C(O)C3)C(C)CC
SuperclassPhenylpropanoids and polyketides
ClassFlavonoids

Pharmacokinetic properties

Number of descriptor values(#stars)1
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)13
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)540.566
Computed dipole moment(dipole)3.406
Total solvent accessible surface area (SASA)813.922
Hydrophobic component of SASA (FOSA)391.61
Hydrophilic component of SASA (FISA)255.753
Pie component of the SASA (PISA)166.559
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1553.76
Number of hydrogen bond donors (donorHB)6
Number of hydrogen bond acceptors (accptHB)8.7
Free energy of solvation of dipole (dip^2/V)0.0074665
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0261825
Globularity descriptor (glob)0.797085
Predicted polarizability in cubic angstroms (QPpolrz)49.271
Predicted hexadecane/gas partition coefficient (QPlogPC16)17.005
Predicted octanol/gas partition coefficient (QPlogPoct)30.178
Predicted water/gas partition coefficient (QPlogPw)19.04
Predicted octanol/water partition coefficient (QPlogPo/w)2.982
Predicted aqueous solubility (QPlogS)-5.177
Conformation-independent predicted aqueous solubility (CIQPlogS)-7.372
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-5.61
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)37.204
Predicted brain/blood partition coefficient (QPlogBB)-2.904
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)14.104
Predicted skin permeability, log Kp (QPlogKp)-4.398
PM3 calculated ionization potential (IP(ev))8.862
PM3 calculated electron affinity (EA(eV))0.211
Number of likely metabolic reactions (#metab)13
Prediction of binding to human serum albumin (QPlogKhsa)0.276
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)46.599
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)170.775
Number of nitrogen and oxygen atoms (#NandO)10
Number of violations of Lipinski’s rule of five (RuleOfFive)2
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SwissTargetPrediction
P43166CA7Carbonic anhydrase VIIT37541SwissTargetPrediction
P22748CA4Carbonic anhydrase IVT53378SwissTargetPrediction
P11926ODC1Ornithine decarboxylaseT60366SEA
P08253MMP2Matrix metalloproteinase 2T68251SwissTargetPrediction
P14780MMP9Matrix metalloproteinase 9T54156SwissTargetPrediction
Q14534SQLESqualene monooxygenase (by homology)T93344SwissTargetPrediction
P56817BACE1Beta-secretase 1T79031SwissTargetPrediction
P20151KLK2Kallikrein 2T01908SEA
P15692VEGFAVascular endothelial growth factor AT20761SwissTargetPrediction and SEA
P49763PGFPlacenta growth factorT70792SwissTargetPrediction and SEA
P52209PGD6-phosphogluconate dehydrogenaseT76497SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T60366DI0020African trypanosomiasis[ICD-11: 1F51]P11926ODC1
T68251DI0238Lung cancer[ICD-11: 2C25]P08253MMP2
T54156DI0219Ischaemic/haemorrhagic stroke[ICD-11: 8B20]P14780MMP9
T54156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P14780MMP9
T54156DI0395Stomach cancer[ICD-11: 2B72]P14780MMP9
T54156DI0419Ulcerative colitis[ICD-11: DD71]P14780MMP9
T93344DI0118Dermatophytosis[ICD-11: 1F28]Q14534SQLE
T93344DI0385Skin fungal infection disorder[ICD-11: EA60]Q14534SQLE
T79031DI0025Alzheimer disease[ICD-11: 8A20]P56817BACE1
T01908DI0213Innate/adaptive immunodeficiency[ICD-11: 4A00]P20151KLK2
T20761DI0095Colorectal cancer[ICD-11: 2B91]P15692VEGFA
T20761DI0365Retinopathy[ICD-11: 9B71]P15692VEGFA
T20761DI0430Vascular system developmental anomaly[ICD-11: LA90]P15692VEGFA
T70792DI0095Colorectal cancer[ICD-11: 2B91]P49763PGF
T76497DI0337Pituitary gland disorder[ICD-11: 5A60-5A61]P52209PGD

Copyright © 2025